androgen-induced sebocyte growth

Prescribing Isotretinoin for Transgender Patients
130081300813008isotretinoin for transgender patientsCase Scenario A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections. He has not had any gender-affirming surgeries and reports being currently amenorrhoeic. He is curren …
isotretinoin for transgender patients